COMP <GO>
CTSH vs VRSK // FORWARD P/E MULTIPLE
Cognizant Technology Solutions Corporation (NASDAQ) VS. Verisk Analytics Inc. (NASDAQ) • 15-METRIC TALLY: CTSH 8
— VRSK 5
▲ FORWARD P/E MULTIPLE LEADER: CTSH
LAST: $65.09 (-0.03%) • MKT CAP: $29.11B
forward-pe
11.7x
LAST: $201.50 (+2.65%) • MKT CAP: $25.55B
forward-pe
25.4x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CTSH VS. VRSK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CTSH | VRSK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 69.90% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.60% | 53.50% | -33.90 | VRSK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 7.4x | 16.2x | -8.80 | CTSH | /valuation <GO> |
| Free Cash Flow Yield | 9.21% | 4.80% | +4.41 | CTSH | /fcf-yield <GO> |
| Operating Margin | 16.10% | 43.70% | -27.60 | VRSK | /operating-margins <GO> |
| Net Profit Margin | 10.60% | 29.60% | -19.00 | VRSK | /net-margins <GO> |
| Revenue Growth (YoY) | 7.00% | 6.60% | +0.40 | CTSH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.17% | 1.01% | +1.16 | CTSH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.80 | 5.60 | +0.20 | CTSH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | CTSH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.6 | 60.0 | -7.40 | VRSK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 1.26 | -0.10 | VRSK | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 11.7x | 25.4x | -13.70 | CTSH | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $29.11B | $25.55B | $3.56B | CTSH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CTSH REV | VRSK REV | CTSH GROSS % | VRSK GROSS % | CTSH FCF | VRSK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $21.11B | $3.07B | — | 69.9% | $2.60B | $1.19B |
| FY 2024 | $19.74B | $2.88B | — | 68.7% | $1.83B | $920.1M |
| FY 2023 | $19.35B | $2.68B | — | — | $1.46B | $940.0M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CTSH // BETA 1.16
VRSK // BETA 1.26